SPIL [SILICONWARE PRECISION INDUSTRIES CO] 6-K: (Original Filing)

[To announce the differences between the 2014 consolidated financial statements of Siliconware Precision Industries Co., Ltd. (the “Company”) prepared under Taiwan IFRS and IFRS as issued by the IASB. (1) Under International Financial Reporting Standards endorsed by the Financial Supervisory Commission of the Republic of China (“Taiwan IFRS”), the Company reported consolidated net income of NT$11,731,202 thousand; basic earnings per]

By | 2016-03-22T09:55:06+00:00 April 27th, 2015|Categories: Chinese Stocks, SEC Original, SPIL|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D/A: Joint Filing Agreement [Remainder of this page has

[Joint Filing Agreement [Remainder of this page has been left intentionally blank.] GOLDEN MEDITECH STEM CELLS (BVI) COMPANY LIMITED GOLDEN MEDITECH HOLDINGS LIMITED BIO GARDEN INC.] [PROPOSAL LETTER GOLDEN MEDITECH HOLDINGS LIMITED April 27 , 201 5 The Board of Directors China Cord Blood Corporation 48/F Bank of China Tower 1 Garden Road, Central Hong Kong S.A.R Dear Sirs : Golden Meditech Holdings Limited, a company incorporated under the laws of the Golden Meditech Cayman Islands (“ Company Acquisition pleased to submit this preliminary non-binding proposal] [27 April 2015 TERM SHEET relating to underwriting for an Open Offer of Golden Meditech Holdings Limited Golden Meditech Holdings Limited AND Bio Garden Inc. Details Date 27 April 2015 Parties Name Golden Meditech Holdings Limited (“Company”) Address 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong Name Bio Garden Inc. (“Bio Garden”) Address Portcullis TrustNet Chambers, PO] []

By | 2016-03-27T09:16:11+00:00 April 27th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CCM [Concord Medical Services] 20-F: (Original Filing)

[None None Indicate the number of outstanding shares of each of the Issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 134,836,300 Class A Ordinary Shares Issued and Outstanding ¨ x ¨ x x ¨ x ¨ ¨ Large accelerated filer x Accelerated filer ¨ Non-accelerated filer x U.S. GAAP] [Concord Medical Services Holdings Ltd. (Cayman) subsidiary Outside PRC Mainland Ascendium Group Limited Cyber Medical Network Limited China Medical Services Holdings Limited Our Medical Services Ltd. CONCORD MEDICAL SERVICES (INTERNATIONAL) Pte. Ltd. King Cheers Holdings Limited US PROTON THERAPY HOLDINGS LIMITED (BVI) US PROTON THERAPY HOLDINGS LIMITED(Delaware) Medstar Overseas Limited(BVI) CCM (HONG KONG)MEDICAL INVESTMENTS LIMITED CMS Radiotherapy Holdings Limited Allcure] [Certification by the Chief Executive Officer Company I, Jianyu Yang, Chief Executive Officer of Concord Medical Services Holdings Limited (the “ 1. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certification by the Chief Financial Officer I, Yaw Kong Yap, Chief Financial Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 1. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [Certification by the Chief Executive Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jianyu Yang Chief Executive Officer EX-13.1 5 d856172dex131.htm EX-13.1] [Certification by the Chief Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yaw Kong Yap Chief Financial Officer EX-13.2 6 d856172dex132.htm EX-13.2]

QIHU [Qihoo 360 Technology Co] 20-F:

[] [QIHOO 360 TECHNOLOGY CO. LTD. AND CITICORP INTERNATIONAL LIMITED, as Trustee INDENTURE Dated as of August 6, 2014 0.50% Convertible Senior Notes due 2020 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions. 1 Section 1.02 References to Interest. 10 Section 1.03 New York Office of Trustee, Conversion Agent, Note Registrar, Paying Agent and Transfer Agent. 11 ARTICLE] [QIHOO 360 TECHNOLOGY CO. LTD. AND CITICORP INTERNATIONAL LIMITED, as Trustee INDENTURE Dated as of August 6, 2014 1.75% Convertible Senior Notes due 2021 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions. 1 Section 1.02 References to Interest. 10 Section 1.03 New York Office of Trustee, Conversion Agent, Note Registrar, Paying Agent and Transfer Agent. 11 ARTICLE] [SHARE SUBSCRIPTION AGREEMENT BY AND AMONG Coolpad E-commerce Inc. Coolpad Group Limited AND TECH TIME DEVELOPMENT LIMITED December 16, 2014 TABLE OF CONTENTS Page Article I Purchase Transactions 1 1.1 Subscription of Company Shares 1 1.2 Closing 1 1.3 Withholding 2 2 2.1 Organization and Corporate Power 2 2.2 Share Capital and Related Matters 3 2.3 Indebtedness 4 2.4 No] [As of December 31, 2014 Wholly-Owned Subsidiaries 1. Qizhi Software (Beijing) Co., Ltd., a PRC company 2. Tianjin Qisi Technology Co., Ltd., a PRC company 3. Qifei Xiangyi (Beijing) Software Co., Ltd., a PRC company 4. Qiji International Development Limited, a HK company 5. 360 International Development Co. Limited, a HK company 6. Qifei International Development Co. Limited, a HK] [CERTIFICATIONS I, Hongyi Zhou, certify that: 1. I have reviewed this annual report on Form 20-F of Qihoo 360 Technology Co. Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATIONS I, Jue Yao, certify that: 1. I have reviewed this annual report on Form 20-F of Qihoo 360 Technology Co. Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATIONS I, Alex Zuoli Xu, certify that: 1. I have reviewed this annual report on Form 20-F of Qihoo 360 Technology Co. Ltd. (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [CERTIFICATIONS (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [[Letterhead of Commerce & Finance Law Offices] April 27, 2015 Qihoo 360 Technology Co. Ltd. Building No. 2 6 Jiuxianqiao Road, Chaoyang District Beijing 100015, People’s Republic of China Dear Sirs: Yours faithfully, Commerce & Finance Law Offices] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We consent to the incorporation by reference in the Registration Statements No. 333-174444, No. 333-190371 and No. 3336-199395 on Form S-8, of our reports dated April 27, 2015, relating to the consolidated financial statements and financial statement schedule of Qihoo 360 Technology Co. Ltd., and its subsidiaries, variable interest entities and variable interest]

By | 2016-03-13T22:49:54+00:00 April 27th, 2015|Categories: Chinese Stocks, QIHU, Webplus ver|Tags: , , , , , |0 Comments

SPIL [SILICONWARE PRECISION INDUSTRIES CO] 6-K: To announce the differences between the 2014 consolidated

[To announce the differences between the 2014 consolidated financial statements of Siliconware Precision Industries Co., Ltd. (the “Company”) prepared under Taiwan IFRS and IFRS as issued by the IASB. (1) Under International Financial Reporting Standards endorsed by the Financial Supervisory Commission of the Republic of China (“Taiwan IFRS”), the Company reported consolidated net income of NT$11,731,202 thousand; basic earnings per]

By | 2016-03-22T09:57:20+00:00 April 27th, 2015|Categories: Chinese Stocks, SPIL, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Receipt of “Going Private” Proposal The Company expects that its board of directors will form a special committee of independent directors (the “Special Committee”) to consider the proposed transaction. The Company also expects that the Special Committee will retain advisors, including an independent financial advisor and legal counsel, to assist it in its work. The] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]

By | 2016-03-27T09:17:23+00:00 April 27th, 2015|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CCM [Concord Medical Services] 20-F: None None Indicate the number of outstanding shares

[None None Indicate the number of outstanding shares of each of the Issuer’s classes of capital or common stock as of the close of the period covered by the annual report. 134,836,300 Class A Ordinary Shares Issued and Outstanding ¨ x ¨ x x ¨ x ¨ ¨ Large accelerated filer x Accelerated filer ¨ Non-accelerated filer x U.S. GAAP] [Concord Medical Services Holdings Ltd. (Cayman) subsidiary Outside PRC Mainland Ascendium Group Limited Cyber Medical Network Limited China Medical Services Holdings Limited Our Medical Services Ltd. CONCORD MEDICAL SERVICES (INTERNATIONAL) Pte. Ltd. King Cheers Holdings Limited US PROTON THERAPY HOLDINGS LIMITED (BVI) US PROTON THERAPY HOLDINGS LIMITED(Delaware) Medstar Overseas Limited(BVI) CCM (HONG KONG)MEDICAL INVESTMENTS LIMITED CMS Radiotherapy Holdings Limited Allcure] [Certification by the Chief Executive Officer Company I, Jianyu Yang, Chief Executive Officer of Concord Medical Services Holdings Limited (the “ 1. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certification by the Chief Financial Officer I, Yaw Kong Yap, Chief Financial Officer of Concord Medical Services Holdings Limited (the “Company”), certify that: 1. 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances] [Certification by the Chief Executive Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jianyu Yang Chief Executive Officer EX-13.1 5 d856172dex131.htm EX-13.1] [Certification by the Chief Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yaw Kong Yap Chief Financial Officer EX-13.2 6 d856172dex132.htm EX-13.2]

CTC [IFM Investments] 20-F: (Original Filing)

[] [Wholly owned subsidiaries : · IFM Company Ltd., incorporated in the Cayman Islands · Beijing Aifeite International Franchise Consultant Co., Ltd., incorporated in the People’s Republic of China 北京埃菲特国际特许经营咨询服务有限公司 ) · City Integrated Residential Services (China) Limited, incorporated in Hong Kong, S.A.R. 泛城(中国)综合住宅服务有限公司 ) · Shanghai Yaye Real Estate Brokerage Co., Ltd., incorporated in the People’s Republic of China 上海亚业房地产经纪有限公司] [Certification by the Chief Executive Officer I, Donald Zhang, certify that: 1. I have reviewed this annual report on Form 20-F of IFM Investments Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Certification by the Chief Financial Officer I, Steve Mao Ye, certify that: 1. I have reviewed this annual report on Form 20-F of IFM Investments Limited (the “Company”); 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [Certification by the Chief Executive Officer (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 27, 2015 Donald Zhang Chief Executive Officer EX-13.1 5 a2222962zex-13_1.htm EX-13.1] [Certification by the Chief Financial Officer (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 27, 2015 Steve Mao Ye Chief Financial Officer EX-13.2 6 a2222962zex-13_2.htm EX-13.2] [Consent of DaHui Lawyers, PRC Counsel IFM Investments Limited Dear Sir or Madam: We hereby consent to the references to us by IFM Investments Limited (the “Company”) under the heading “Risks Related to Doing Business in China” in the Annual Report on Form 20-F of the Company for the year ended December 31, 2014. Yours faithfully, For and on behalf] [Consent of Independent Registered Public Accounting Firm We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-169542) and Form F-3 (No. 333-169541) of IFM Investments Limited of our report dated April 27, 2015 relating to the consolidated financial statements, which appears in this Form 20-F. April 27, 2015 EX-15.2 8 a2222962zex-15_2.htm EX-15.2] [April 27, 2015 100 F Street, N.E. Commissioners: Very truly yours, EX-15.3 9 a2222962zex-15_3.htm EX-15.3]

SPIL [SILICONWARE PRECISION INDUSTRIES CO] 20-F: (Original Filing)

[SILICONWARE PRECISION INDUSTRIES CO., LTD. FORM 20-F ANNUAL REPORT FISCAL YEAR ENDED DECEMBER 31, 2014 Page Supplemental Information 1 1 PART I 2 Item 1. Identity of Directors, Senior Management and Advisers 2 Item 2. Offer Statistics and Expected Timetable 2 Item 3. Key Information 2 Item 4. Information on the Company 19 Item 4A. Unresolved Staff Comments 32 Item] [LIST OF SIGNIFICANT SUBSIDIARIES OF SILICONWARE PRECISION INDUSTRIES CO., LTD. Company Jurisdiction of Incorporation Percentage Ownership As of December 31, 2014 SPIL (B.V.I.) Holding Limited British Virgin Islands 100 % Siliconware U.S.A. Inc. 100 % SPIL (Cayman) Holding Limited Cayman Islands 100 % Siliconware Technology (Suzhou) Limited People’s Republic of China 100 % EX-8.1 2 d913005dex81.htm EX-8.1] [CERTIFICATION OF OUR CHIEF EXECUTIVE OFFICER I, Chi-Wen Tsai, certify that: 1. I have reviewed this annual report on Form 20-F of Siliconware Precision Industries Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF OUR CHIEF FINANCIAL OFFICER I, Eva Chen, certify that: 1. I have reviewed this annual report on Form 20-F of Siliconware Precision Industries Co., Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PERIODIC FINANCIAL REPORT 1. 2. The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the company. Chi-Wen Tsai Chief Executive Officer * A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the company and will] [CERTIFICATION OF PERIODIC FINANCIAL REPORT 1. 2. The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the company. Eva Chen Chief Financial Officer * A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the company and will]

By | 2016-03-22T09:58:43+00:00 April 27th, 2015|Categories: Chinese Stocks, SEC Original, SPIL|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Receipt of “Going

[China Cord Blood Corporation Announces Receipt of “Going Private” Proposal The Company expects that its board of directors will form a special committee of independent directors (the “Special Committee”) to consider the proposed transaction. The Company also expects that the Special Committee will retain advisors, including an independent financial advisor and legal counsel, to assist it in its work. The] [FORM 6-K Commission Filing Number: 001-34541 CHINA CORD BLOOD CORPORATION 48th Floor, Bank of China Tower 1 Garden Road Central Hong Kong S.A.R. Form 20-F x Form 40-F o o o Description]

By | 2016-03-27T09:18:37+00:00 April 27th, 2015|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar